Breaking News

Financial Report: Charles River Laboratories

PCS sales up 6% in the quarter

Related CONTENT

05.02.13

Charles River Laboratories

1Q Revenues: $291.2 million (+2%)

1Q Earnings: $25.8 million (-3%)

Comments: Research Models and Services (RMS) sales were flat at $182.5 million in the quarter. Excluding foreign exchange, RMS sales increased 1%. Preclinical Services (PCS) sales were $108.7 million, up 6%, driven by increased sales to large biopharma and mid-tier clients, primarily as a result of continued market share gains.

Suggested For You

Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer

Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer

Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate

Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate

Albumedix Extends Research Collaboration with Cobra Biologics

Albumedix Extends Research Collaboration with Cobra Biologics

Charles River Acquires Retrogenix

Charles River Acquires Retrogenix

Charles River Acquires CDMO Cognate BioServices

Charles River Acquires CDMO Cognate BioServices

Charles River Partners with JADE

Charles River Partners with JADE

Charles River Labs Acquires Distributed Bio

Charles River Labs Acquires Distributed Bio

Charles River Laboratories

Charles River Laboratories

PathoQuest, Charles River Expand Strategic Pact

PathoQuest, Charles River Expand Strategic Pact

Saneca Pharma Expands Services in Russia

Saneca Pharma Expands Services in Russia

Norgine Buys Merus Labs for $342M

Norgine Buys Merus Labs for $342M

Financial Report: AMRI

Financial Report: AMRI

Financial Report: Regeneron

Financial Report: Regeneron

Financial Report: Merck

Financial Report: Merck

Overcoming Preclinical Drug Development Hurdles

Overcoming Preclinical Drug Development Hurdles

Related Breaking News

Breaking News | Drug Development

Astellas Pharma and Dyno Therapeutics Sign Option and License Agreement

Will collaborate to develop next-gen AAV gene therapy vectors for skeletal and cardiac muscle.
12.02.21
Breaking News | Industry News | Vials

SCHOTT Continues to Expand U.S. Presence

Setting a strategic portfolio in the U.S. aims to capitalize on the world’s largest economy and capacity for innovation.
12.02.21
Breaking News | Clinical Trials

Sotio Biotech Secures Funding to Expand & Advance Its Clinical Pipeline

Proceeds will be used to conduct two phase 2 studies with SOT101, including a checkpoint inhibitor combination trial.
12.02.21
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

FUJIFILM Diosynth Biotechnologies Invests £400M in UK Bio-Mfg. Site

Expansion will more than double the site’s development and manufacturing footprint and is expected to create as many as 350 highly-skilled jobs in Teesside.
12.02.21
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

CordenPharma Expands Specialty Lipids Production in Chenôve

Invests in Supercritical Fluid Chromatography technology for compound separation, an efficient and cost-effective process for purifying lipids.
12.02.21
Breaking News

Fujifilm Irvine Scientific to Establish New Innovation & Collaboration Center in China

Construction has begun in Suzhou and is planned for completion by March, 2022.
12.01.21
Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Drug Development | Formulation Development | Industry News

Adare Pharma Solutions Acquires Frontida BioPharm

Expands CDMO offerings to include new capabilities such as high potency compound handling and packaging services.
12.01.21
Breaking News | cGMP Manufacture | Collaborations & Alliances

Evergreen Theragnostics to Manufacture MTTI’s EvaThera Radiopharmaceuticals Platform

New technology has the potential to make a meaningful improvement in the lives of patients.
12.01.21
Breaking News | Capsules | Industry News | Solid Dosage/Semi-solids

Jones Healthcare Expands Medication Adherence Packaging Offering

New Qube and FlexRx Blister Packs designed for pharmacy automation, first to use eco-friendly bio-PET material.
12.01.21
Analytical Services | Breaking News | cGMP Manufacture | Industry News | Methods Development | Regulatory Affairs

WuXi STA, Coherent Biopharma Enter Strategic PDC Pact

WuXi STA to provide peptide platform services from drug discovery to commercial manufacturing to support Coherent’s PDC drug candidate development.
12.01.21
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Emergex T-Cell Priming COVID Vax Candidate Holds Potential Against Omicron

Phase I vaccine candidate has the potential to be effective against all currently known variants and would eliminate the need for seasonal booster.
11.30.21
Breaking News | Drug Discovery | Promotions & Moves

Metrion Biosciences Appoints Dr. Roy Curtis as VP U.S. Commercial Operations

Curtis will support the company’s goal to become the leading global ion channel service provider.
11.30.21
Breaking News | Collaborations & Alliances | Drug Development | R&D

NovAliX Partners with Sanofi for the Development of New DNA-Encoded Libraries

Agreement strengthens NovAliX’s industrial and technological foothold within the drug discovery sector.
11.30.21
APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Excipients | Industry News

CordenPharma Invests €9.7M in New CTD Facility at Plankstadt CoE

To design and install GMP Clinical Trial Development facility for the manufacture of oral solid dosage drug products.
11.30.21
Breaking News | cGMP Manufacture | Drug Development | Industry News

Lonza Inks Development and Mfg. Pact for Bioqube’s Portfolio Co.s

Lonza to provide tailored services for molecules ranging from monoclonal antibodies, complex proteins, and small molecules to antibody-drug conjugates.
11.30.21